Fitbit’s AFib detection algorithm passes FDA

Fitbit, owned by Google, will make it possible to detect a potential problem by monitoring the heart rhythms of users with a new technology it has developed. The company’s AFib detection algorithm has received FDA approval, and soon certain Fitbit wearables will be able to detect and notify users of irregular heart rhythm.

Offers high accuracy

Google has announced that Fitbit’s algorithm can detect atrial fibrillation (AFib or AF), an irregular heartbeat condition that can lead to blood clots, stroke, heart failure, and other heart-related complications. and the Drug Administration (FDA) announced that it has received approval.

The company’s PPG(photoplethysmography) AFib algorithm was created with data from a study started in 2020 that enrolled 455,699 participants over five months. According to Fitbit, PPG detections were able to accurately identify AFib events 98% of the time.

Fitbit, While it says the algorithm will soon be available to consumers in the US on a variety of heart rate-enabled devices, the emerging information shows that the algorithm is currently available on Fitbit Sense and Fitbit Charge 5 devices via the EKG app.